Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Pragma Bio
Pragma Bio discovers microbiome-based therapies and biomarkers to improve outcomes for cancer and autoimmune patients. The company combines genomic sequencing, artificial intelligence, and synthetic…
Pragma Bio
Pragma Bio discovers microbiome-based therapies and biomarkers to improve outcomes for cancer and autoimmune patients. The company combines genomic sequencing, artificial intelligence, and synthetic…
TL;DR
Focus: Microbiome-based therapies and biomarkers for cancer and autoimmune indications
Platform: AI-enabled biology-first platform (PIKASO) combining bioinformatics, synthetic biology, and medchem
Founded: 2018–2019 (company origins reported 2018; snapshot lists 2019)
HQ: San Francisco Bay Area (South San Francisco / Millbrae area)
Recent financing: Series A announced Mar 2023 (reported ~$10M)
Company Overview
Problem Domain
Therapeutics and biomarker discovery at the intersection of microbiome biology and immunology (cancer, autoimmune, immune-related indications).
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
10000000
Reported Series A announced March 22, 2023 (TechCrunch reported ~$10M)
Investor Signal
“Backed by venture and strategic investors including The Venture Collective, Viking Global Investors, Merck Global Health Innovation Fund, Iaso Ventures, Good AI Capital, CJ Investment”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week